论文信息 - Abstract P5-20-19: PAM50 intrinsic subtype predicts survival outcome in HER2-positive/hormone receptor-positive metastatic breast cancer treated with palbociclib and trastuzumab: a correlative analysis of the PATRICIA (SOLTI 13-03) trial - 字舞流文

Abstract P5-20-19: PAM50 intrinsic subtype predicts survival outcome in HER2-positive/hormone receptor-positive metastatic breast cancer treated with palbociclib and trastuzumab: a correlative analysis of the PATRICIA (SOLTI 13-03) trial

P. Nuciforo | A. Prat | B. Adamo | P. Villagrasa | S. Morales | J. Cortés | B. Bermejo | P. Galván | M. V. Oliveira | J. Soberino | T. Pascual | L. Paré | E. Martínez | N. Martínez | M. Melé | S. Pernas | E. Ciruelos | I. Garau | S. Vázquez | A. Perelló | L. Peña | X. Gonzàlez